Case study of LVAD therapy in a young patient with the rare heart condition, giant cell myocarditis

Patient

  • 37-year-old woman with the rare heart condition, giant cell myocarditis

Clinical Progression

  • Presented with cardiogenic shock and was placed on Extracorporeal Membrane Oxygenation (ECMO).Initially received a HeartWare® LVAD and a CentriMag® right ventricular assist device.
  • Developed heparin-induced thrombocytopenia, and as a result, clotted the LVAD.
  • Additional surgery performed to remove pump and the majority of the heart and replace entire system with original Thoratec pump, T-VAD®, an external pump connected to pipes inside the body.

Prognosis

  • Excellent. After close to ten surgeries and the entire spectrum of available pumps, the goal is heart transplantation.

Leave a comment

Filed under Patient Care, Research, Treatments

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s